Royce & Associates’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Sell |
521,805
-338,939
| -39% | -$7.3M | 0.12% | 256 |
|
|
2025
Q1 | $19.7M | Buy |
860,744
+83,462
| +11% | +$1.91M | 0.21% | 142 |
|
|
2024
Q4 | $20.2M | Sell |
777,282
-47,851
| -6% | -$1.24M | 0.19% | 159 |
|
|
2024
Q3 | $20.7M | Sell |
825,133
-87,519
| -10% | -$2.19M | 0.19% | 153 |
|
|
2024
Q2 | $19.6M | Buy |
912,652
+397,445
| +77% | +$8.52M | 0.18% | 157 |
|
|
2024
Q1 | $9.56M | Sell |
515,207
-356,396
| -41% | -$6.61M | 0.09% | 344 |
|
|
2023
Q4 | $14.2M | Buy |
871,603
+628,827
| +259% | +$10.2M | 0.13% | 212 |
|
|
2023
Q3 | $3.35M | Buy |
+242,776
| New | +$3.35M | 0.03% | 561 |
|
|
2022
Q4 | – | Sell |
-21,600
| Closed | -$491K | – | 915 |
|
|
2022
Q3 | $491K | Sell |
21,600
-200
| -0.9% | -$4.55K | 0.01% | 819 |
|
|
2022
Q2 | $301K | Buy |
+21,800
| New | +$301K | ﹤0.01% | 884 |
|
|
2022
Q1 | – | Sell |
-57,300
| Closed | -$2.14M | – | 964 |
|
|
2021
Q4 | $2.14M | Sell |
57,300
-129,856
| -69% | -$4.84M | 0.02% | 718 |
|
|
2021
Q3 | $7.92M | Buy |
187,156
+1,960
| +1% | +$82.9K | 0.06% | 481 |
|
|
2021
Q2 | $8.24M | Sell |
185,196
-116,300
| -39% | -$5.18M | 0.06% | 480 |
|
|
2021
Q1 | $10.9M | Sell |
301,496
-543,620
| -64% | -$19.6M | 0.07% | 419 |
|
|
2020
Q4 | $33.7M | Hold |
845,116
| – | – | 0.28% | 81 |
|
|
2020
Q3 | $24.5M | Buy |
845,116
+165,500
| +24% | +$4.79M | 0.26% | 91 |
|
|
2020
Q2 | $11.1M | Buy |
679,616
+198,900
| +41% | +$3.25M | 0.12% | 235 |
|
|
2020
Q1 | $4.57M | Buy |
480,716
+260,000
| +118% | +$2.47M | 0.06% | 399 |
|
|
2019
Q4 | $3.57M | Buy |
220,716
+24,061
| +12% | +$389K | 0.03% | 570 |
|
|
2019
Q3 | $3.27M | Buy |
196,655
+10,000
| +5% | +$166K | 0.03% | 585 |
|
|
2019
Q2 | $3.16M | Buy |
+186,655
| New | +$3.16M | 0.03% | 612 |
|